Johnson & Johnson (JNJ) chief executive officer Alex Gorsky was initially chastised last week for deciding to stay on President Trump’s manufacturing advisory council, before reversing course just as Trump announced the panel would be dissolved after a series of defections.

A trio of internal memos sent to J&J employees, reviewed by STAT, offer some insight into Gorsky’s reasoning.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • The adage is if you want to join the club you have to pay your dues, even if it pisses off a few shareholders. Frazier and Gorsky have lost their seats at the adult table even if the councils have been dissolved.

  • I am puzzled by the last sentence of this article. The whole article is about the J and J CEO’s thought process as events unfolded. The article answers the question in the last sentence. The answer to that question is essentially why the article was written.

    • Hi TJ,

      Thanks for the note. I was attempting to offer my own thought – if Frazier could take a stand after Trump’s initial remarks, why couldn’t Gorsky?

      Yes, Gorsky did attempt to address that in his memos/blog posts, but I also think he danced around that issue.

      In short, I think Gorsky – and all of the council members – should have resigned sooner, and I was addressing the question to readers. Maybe others agree that his answers didn’t cut it. I was simply trying to prompt some thought.

      ed at pharmalot

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy